Group One Trading
ELOX

Group One Trading’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Group One Trading’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,285
Closed -$475K – 9087
2021
Q3 		$475K Buy
7,285
+3,682
+102% +$227K ﹤0.01% 4243
2021
Q2 		$287K Buy
+3,603
New +$301K ﹤0.01% 4828

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Group One Trading's ELOX Position: Q4 2023 in Review

Group One Trading sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2023, closing a stake of 4 shares — an estimated $19 sold.

Group One Trading first reported a position in ELOX in Q4 2021 and held it in 8 quarters. The position peaked at $44K in Q1 2022. 4 funds tracked by Wall St. Rank hold ELOX as of Q4 2023.

  • Group One Trading reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 4 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $19.
  • Group One Trading first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Group One Trading's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $44K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.